Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.

Burns DM, Ryan GB, Harvey CM, Nagy E, Hughes S, Murray PG, Russell NH, Fox CP, Long HM.

Front Immunol. 2019 Oct 29;10:2489. doi: 10.3389/fimmu.2019.02489. eCollection 2019.

2.

Glenoid component positioning and guidance techniques in anatomic and reverse total shoulder arthroplasty: A systematic review and meta-analysis.

Burns DM, Frank T, Whyne CM, Henry PD.

Shoulder Elbow. 2019 Jul;11(2 Suppl):16-28. doi: 10.1177/1758573218806252. Epub 2018 Oct 26. Review.

PMID:
31447941
3.

Data interoperability is far more valuable and feasible than a single electronic health record.

Burns DM.

CMAJ. 2019 May 27;191(21):E587. doi: 10.1503/cmaj.71915. No abstract available.

PMID:
31133608
4.

Multivariate multiple regression models of poly(ethylene-terephthalate) film degradation under outdoor and multi-stressor accelerated weathering exposures.

Gordon DA, Huang WH, Burns DM, French RH, Bruckman LS.

PLoS One. 2018 Dec 20;13(12):e0209016. doi: 10.1371/journal.pone.0209016. eCollection 2018.

5.

Saturated Salt Solution Cadaver-Embalming Method Improves Orthopaedic Surgical Skills Training.

Burns DM, Bell I, Katchky R, Dwyer T, Toor J, Whyne CM, Safir O.

J Bone Joint Surg Am. 2018 Aug 1;100(15):e104. doi: 10.2106/JBJS.17.01256.

PMID:
30063602
6.

Shoulder physiotherapy exercise recognition: machine learning the inertial signals from a smartwatch.

Burns DM, Leung N, Hardisty M, Whyne CM, Henry P, McLachlin S.

Physiol Meas. 2018 Jul 23;39(7):075007. doi: 10.1088/1361-6579/aacfd9.

PMID:
29952759
7.

Low-dose lithium regimen enhances endochondral fracture healing in osteoporotic rodent bone.

Vachhani K, Whyne C, Wang Y, Burns DM, Nam D.

J Orthop Res. 2018 Jun;36(6):1783-1789. doi: 10.1002/jor.23799. Epub 2017 Nov 28.

8.

Discovery of novel determinants of endothelial lineage using chimeric heterokaryons.

Wong WT, Matrone G, Tian X, Tomoiaga SA, Au KF, Meng S, Yamazoe S, Sieveking D, Chen K, Burns DM, Chen JK, Blau HM, Cooke JP.

Elife. 2017 Mar 21;6. pii: e23588. doi: 10.7554/eLife.23588.

9.

Diagnosis of Engaging Bipolar Bone Defects in the Shoulder Using 2-Dimensional Computed Tomography: A Cadaveric Study.

Burns DM, Chahal J, Shahrokhi S, Henry P, Wasserstein D, Whyne C, Theodoropoulos J, Ogilvie-Harris D, Dwyer T.

Am J Sports Med. 2016 Nov;44(11):2771-2777. Epub 2016 Aug 5.

PMID:
27496905
10.

Garner interference is not solely driven by stimulus uncertainty.

Burns DM.

Psychon Bull Rev. 2016 Dec;23(6):1846-1853.

PMID:
27246090
11.

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.

Burns DM, Rana S, Martin E, Nagra S, Ward J, Osman H, Bell AI, Moss P, Russell NH, Craddock CF, Fox CP, Chaganti S.

Bone Marrow Transplant. 2016 Jun;51(6):825-32. doi: 10.1038/bmt.2016.19. Epub 2016 Feb 22.

12.

Evaluating the Safety of Somatic Periosteal Cells by Flow-Cytometric Analysis Monitoring the History of DNA Damage.

Kawase T, Hayama K, Tsuchimochi M, Nagata M, Okuda K, Yoshie H, Burns DM, Nakata K.

Biopreserv Biobank. 2016 Apr;14(2):129-37. doi: 10.1089/bio.2015.0072. Epub 2016 Feb 1.

PMID:
26828697
13.

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.

Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock CF, Moss P, Rickinson AB, Rowe M, Bell AI.

Blood. 2015 Dec 17;126(25):2665-75. doi: 10.1182/blood-2015-08-665000. Epub 2015 Oct 8.

14.

X-ray and ultraviolet C irradiation-induced γ-H2AX and p53 formation in normal human periosteal cells in vitro: markers for quality control in cell therapy.

Kawase T, Kamiya M, Hayama K, Nagata M, Okuda K, Yoshie H, Burns DM, Tsuchimochi M, Nakata K.

Cytotherapy. 2015 Jan;17(1):112-23. doi: 10.1016/j.jcyt.2014.08.005. Epub 2014 Oct 5.

PMID:
25293814
15.

Changing rates of adenocarcinoma of the lung.

Burns DM.

Chem Res Toxicol. 2014 Aug 18;27(8):1330-5. doi: 10.1021/tx500161m. Epub 2014 Jul 18.

PMID:
25036935
16.

Real-time quantitative polymerase chain reaction and flow cytometric analyses of cell adhesion molecules expressed in human cell-multilayered periosteal sheets in vitro.

Kawase T, Uematsu K, Kamiya M, Nagata M, Okuda K, Burns DM, Nakata K, Yoshie H.

Cytotherapy. 2014 May;16(5):653-61. doi: 10.1016/j.jcyt.2013.11.003. Epub 2014 Jan 11.

PMID:
24418404
17.

Biomechanical evaluation by AFM of cultured human cell-multilayered periosteal sheets.

Horimizu M, Kawase T, Tanaka T, Okuda K, Nagata M, Burns DM, Yoshie H.

Micron. 2013 May;48:1-10. doi: 10.1016/j.micron.2013.02.001. Epub 2013 Feb 11.

PMID:
23490209
18.

Functional principal components analysis of workload capacity functions.

Burns DM, Houpt JW, Townsend JT, Endres MJ.

Behav Res Methods. 2013 Dec;45(4):1048-57. doi: 10.3758/s13428-013-0333-2.

19.

A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells.

Bhutani N, Decker MN, Brady JJ, Bussat RT, Burns DM, Corbel SY, Blau HM.

FASEB J. 2013 Mar;27(3):1107-13. doi: 10.1096/fj.12-222125. Epub 2012 Dec 4.

20.

Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RS™): In vitro expansion of CD146-positive cells and concomitant upregulation of osteogenic potential in vivo.

Uematsu K, Kawase T, Nagata M, Suzuki K, Okuda K, Yoshie H, Burns DM, Takagi R.

Stem Cell Res. 2013 Jan;10(1):1-19. doi: 10.1016/j.scr.2012.08.006. Epub 2012 Sep 6.

21.

Menthol cigarettes and mortality: keeping focus on the public health standard.

Villanti AC, Giovino GA, Burns DM, Abrams DB.

Nicotine Tob Res. 2013 Feb;15(2):617-8. doi: 10.1093/ntr/nts176. Epub 2012 Sep 18. No abstract available.

PMID:
22990220
22.

Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death.

Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns DM.

Risk Anal. 2012 Jul;32 Suppl 1:S25-38. doi: 10.1111/j.1539-6924.2011.01662.x.

23.

Chapter 2: Birth-cohort-specific estimates of smoking behaviors for the U.S. population.

Anderson CM, Burns DM, Dodd KW, Feuer EJ.

Risk Anal. 2012 Jul;32 Suppl 1:S14-24. doi: 10.1111/j.1539-6924.2011.01703.x.

24.

The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.

Ayo-Yusuf OA, Burns DM.

Tob Control. 2012 Mar;21(2):245-51. doi: 10.1136/tobaccocontrol-2011-050367. Review.

PMID:
22345261
25.

DNA demethylation dynamics.

Bhutani N, Burns DM, Blau HM.

Cell. 2011 Sep 16;146(6):866-72. doi: 10.1016/j.cell.2011.08.042.

26.

Improved adhesion of human cultured periosteal sheets to a porous poly(L-lactic acid) membrane scaffold without the aid of exogenous adhesion biomolecules.

Kawase T, Tanaka T, Nishimoto T, Okuda K, Nagata M, Burns DM, Yoshie H.

J Biomed Mater Res A. 2011 Jul;98(1):100-13. doi: 10.1002/jbm.a.33074. Epub 2011 May 4.

PMID:
21544931
27.

CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation.

Burns DM, D'Ambrogio A, Nottrott S, Richter JD.

Nature. 2011 May 5;473(7345):105-8. doi: 10.1038/nature09908. Epub 2011 Apr 10.

28.

Manual cryopreservation of human alveolar periosteal tissue segments: Effects of pre-culture on recovery rate.

Kawase T, Kogami H, Nagata M, Uematsu K, Okuda K, Burns DM, Yoshie H.

Cryobiology. 2011 Jun;62(3):202-9. doi: 10.1016/j.cryobiol.2011.03.004. Epub 2011 Apr 3.

PMID:
21466797
29.

Has the lung cancer risk from smoking increased over the last fifty years?

Burns DM, Anderson CM, Gray N.

Cancer Causes Control. 2011 Mar;22(3):389-97. doi: 10.1007/s10552-010-9708-1. Epub 2010 Dec 25.

30.

Do changes in cigarette design influence the rise in adenocarcinoma of the lung?

Burns DM, Anderson CM, Gray N.

Cancer Causes Control. 2011 Jan;22(1):13-22. doi: 10.1007/s10552-010-9660-0. Epub 2010 Oct 22.

31.

Smoking cessation and relapse during a lung cancer screening program.

Anderson CM, Yip R, Henschke CI, Yankelevitz DF, Ostroff JS, Burns DM.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3476-83. doi: 10.1158/1055-9965.EPI-09-0176.

32.

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.

Burns DM, Li YL, Shi E, He C, Xu M, Zhuo J, Zhang C, Qian DQ, Li Y, Wynn R, Covington MB, Katiyar K, Marando CA, Fridman JS, Scherle P, Friedman S, Metcalf B, Yao W.

Bioorg Med Chem Lett. 2009 Jul 1;19(13):3525-30. doi: 10.1016/j.bmcl.2009.04.143. Epub 2009 May 5.

PMID:
19457660
33.

Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.

Burns DM, Ying W, Kauppinen TM, Zhu K, Swanson RA.

PLoS One. 2009;4(3):e4896. doi: 10.1371/journal.pone.0004896. Epub 2009 Mar 25.

34.

CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation.

Burns DM, Richter JD.

Genes Dev. 2008 Dec 15;22(24):3449-60. doi: 10.1101/gad.1697808.

35.

A population-based examination of racial and ethnic differences in receiving physicians' advice to quit smoking.

Reed MB, Burns DM.

Nicotine Tob Res. 2008 Sep;10(9):1487-94. doi: 10.1080/14622200802323217.

PMID:
19023840
36.

Live fast, die young, leave a good-looking corpse.

Burns DM.

Arch Intern Med. 2008 Oct 13;168(18):1946-7. doi: 10.1001/archinte.168.18.1946. No abstract available.

PMID:
18852393
37.

Reducing toxic chemical levels in cigarette smoke.

Burns DM.

Public Health Rep. 2008 Sep-Oct;123(5):552-3; author reply 553. No abstract available.

38.

COPD-related morbidity and mortality after smoking cessation: status of the evidence.

Godtfredsen NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C, Burns DM, Prescott E, Vestbo J.

Eur Respir J. 2008 Oct;32(4):844-53. doi: 10.1183/09031936.00160007. Review.

39.

Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal.

Burns DM, Dybing E, Gray N, Hecht S, Anderson C, Sanner T, O'Connor R, Djordjevic M, Dresler C, Hainaut P, Jarvis M, Opperhuizen A, Straif K.

Tob Control. 2008 Apr;17(2):132-41. doi: 10.1136/tc.2007.024158. No abstract available.

40.

The effect of cigarette price increases on smoking cessation in California.

Reed MB, Anderson CM, Vaughn JW, Burns DM.

Prev Sci. 2008 Mar;9(1):47-54. doi: 10.1007/s11121-008-0081-1. Epub 2008 Feb 7.

PMID:
18256936
41.

Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.

Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W.

Bioorg Med Chem Lett. 2008 Jan 15;18(2):560-4. Epub 2007 Nov 28.

PMID:
18068976
42.

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.

Yao W, Zhuo J, Burns DM, Li YL, Qian DQ, Zhang C, He C, Xu M, Shi E, Li Y, Marando CA, Covington MB, Yang G, Liu X, Pan M, Fridman JS, Scherle P, Wasserman ZR, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):159-63. Epub 2007 Nov 4.

PMID:
18036818
43.
44.

Association between home smoking restrictions and changes in smoking behaviour among employed women.

Shopland DR, Anderson CM, Burns DM.

J Epidemiol Community Health. 2006 Sep;60 Suppl 2:44-50.

45.

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer.

Yao W, Zhuo J, Burns DM, Xu M, Zhang C, Li YL, Qian DQ, He C, Weng L, Shi E, Lin Q, Agrios C, Burn TC, Caulder E, Covington MB, Fridman JS, Friedman S, Katiyar K, Hollis G, Li Y, Liu C, Liu X, Marando CA, Newton R, Pan M, Scherle P, Taylor N, Vaddi K, Wasserman ZR, Wynn R, Yeleswaram S, Jalluri R, Bower M, Zhou BB, Metcalf B.

J Med Chem. 2007 Feb 22;50(4):603-6. Epub 2007 Jan 26.

PMID:
17256836
46.

The temporal relationship between advertising and sales of low-tar cigarettes.

Reed MB, Anderson CM, Burns DM.

Tob Control. 2006 Dec;15(6):436-41.

47.

Measuring progress to protect workers from job-related secondhand smoke in Texas.

Patt DA, Shopland DR, Anderson CM, Burns DM, Dunnington J, Gritz ER.

Tex Med. 2005 Dec;101(12):50-6.

PMID:
17094502
48.

A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.

Haque T, Johannessen I, Dombagoda D, Sengupta C, Burns DM, Bird P, Hale G, Mieli-Vergani G, Crawford DH.

J Infect Dis. 2006 Sep 1;194(5):584-7. Epub 2006 Jul 25.

PMID:
16897655
50.

Guidance for research and testing to reduce tobacco toxicant exposure.

Henningfield JE, Burns DM, Dybing E.

Nicotine Tob Res. 2005 Dec;7(6):821-6. Review. No abstract available.

PMID:
16298717

Supplemental Content

Loading ...
Support Center